CD8A and neoplasm: Type I IFN markedly promotes the differentiation of human blood monocytes into dendritic cells that exhibit strong in vitro and in vivo capacity to induce a cytotoxic response and cross-priming of CD8+ T cells against exogenous viral or tumor associated antigens [15], [30], [31].